CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Neervannan Seshadri Chief Operating Officer | Gift | −950 | 79,183 | ||
| 2025-12-16 | Neervannan Seshadri Chief Operating Officer | Gift | +475 | 475 | ||
| 2025-12-16 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −2,078 | $79.50 | $165K | 21,941 |
| 2025-12-15 | Goodrich Katherine Director | Option exercise | +2,233 | 2,233 | ||
| 2025-12-15 | Goodrich Katherine Director | Option exercise · Restricted Stock Units | −2,233 | 4,467 | ||
| 2025-12-15 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise | +6,819 | 24,019 | ||
| 2025-12-15 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise · Restricted Stock Units | −6,819 | 20,459 | ||
| 2025-12-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −5,046 | $80.80 | $408K | 136,286 |
| 2025-12-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −6,306 | $81.75 | $516K | 129,980 |
| 2025-12-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −1,148 | $82.39 | $95K | 128,832 |
| 2025-12-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −5,680 | $80.71 | $458K | 4,766 |
| 2025-12-15 | LINK WILLIAM J PHD Director | Sale 10b5-1 | −4,766 | $81.50 | $388K | 0 |
| 2025-12-04 | Azamian Bobak R. President/CEO and Board Chair | Gift | −51,885 | 1,750 | ||
| 2025-09-24 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −6,000 | $55.37 | $332K | 812,106 |
| 2025-09-16 | LINK WILLIAM J PHD Director | Gift | −2,000 | 141,332 | ||
| 2025-09-15 | Morrison Scott W Director | Option exercise | +1,334 | 4,684 | ||
| 2025-09-15 | Morrison Scott W Director | Option exercise · Restricted Stock Units | −1,334 | 0 | ||
| 2025-09-08 | LINK WILLIAM J PHD Director | Sale | −27,116 | $57.00 | $1.5M | 143,332 |
| 2025-08-11 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −6,000 | $50.00 | $300K | 818,106 |
| 2025-06-17 | Farrow Jeffrey S See Remarks | Sale | −13,608 | $40.42 | $550K | 36,704 |
Page 8 of 13 · 257 trades